XORTX Announces Type D Meeting with FDA to be held May 1,
● Type D Meeting Requested to Accelerate XRx-008 Clinical Program ● CALGARY, Alberta, March 14, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc....
Nick Rigopulos Allen Davidoff David Melamed Therapeutics Inc European Medicines Agency Drug Administration
Source: globenewswire.com